EDGAR Filing Documents for 0001493152-23-012632

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001493152-23-012632

Filing Date

2023-04-18

Accepted

2023-04-17 18:29:18

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-k.htm iXBRL	10-K	807081
2		ex4-1.htm	EX-4.1	22526
3		ex31.htm	EX-31	11680
4		ex32.htm	EX-32	6472
5		form10-k_001.jpg	GRAPHIC	28324
6		form10-k_002.jpg	GRAPHIC	28673
7		form10-k_003.jpg	GRAPHIC	32672
8		form10-k_004.jpg	GRAPHIC	40324
9		form10-k_005.jpg	GRAPHIC	27607
10		form10-k_006.jpg	GRAPHIC	13063
11	GRAPHIC	auditreport_001.jpg	GRAPHIC	10564
12	GRAPHIC	auditreport_002.jpg	GRAPHIC	7212
13	GRAPHIC	auditreport_003.jpg	GRAPHIC	1794
	Complete submission text file	0001493152-23-012632.txt		2646625

Data Files

Seq	Description	Document	Type	Size
14	XBRL SCHEMA FILE	npls-20221231.xsd	EX-101.SCH	10607
15	XBRL CALCULATION FILE	npls-20221231_cal.xml	EX-101.CAL	18735
16	XBRL DEFINITION FILE	npls-20221231_def.xml	EX-101.DEF	18651
17	XBRL LABEL FILE	npls-20221231_lab.xml	EX-101.LAB	102706
18	XBRL PRESENTATION FILE	npls-20221231_pre.xml	EX-101.PRE	76009
35	EXTRACTED XBRL INSTANCE DOCUMENT	form10-k_htm.xml	XML	198500

Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506

Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 (925)-362-3169

NP Life Sciences Health Industry Group Inc. (Filer) CIK: 0001781726 (see all company filings)